1. Home
  2. VSTM vs SCHL Comparison

VSTM vs SCHL Comparison

Compare VSTM & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • SCHL
  • Stock Information
  • Founded
  • VSTM 2010
  • SCHL 1920
  • Country
  • VSTM United States
  • SCHL United States
  • Employees
  • VSTM N/A
  • SCHL N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • SCHL Books
  • Sector
  • VSTM Health Care
  • SCHL Consumer Discretionary
  • Exchange
  • VSTM Nasdaq
  • SCHL Nasdaq
  • Market Cap
  • VSTM 425.9M
  • SCHL 478.8M
  • IPO Year
  • VSTM 2012
  • SCHL 1987
  • Fundamental
  • Price
  • VSTM $6.06
  • SCHL $16.95
  • Analyst Decision
  • VSTM Strong Buy
  • SCHL
  • Analyst Count
  • VSTM 9
  • SCHL 0
  • Target Price
  • VSTM $13.63
  • SCHL N/A
  • AVG Volume (30 Days)
  • VSTM 2.1M
  • SCHL 246.5K
  • Earning Date
  • VSTM 05-13-2025
  • SCHL 07-17-2025
  • Dividend Yield
  • VSTM N/A
  • SCHL 4.63%
  • EPS Growth
  • VSTM N/A
  • SCHL N/A
  • EPS
  • VSTM N/A
  • SCHL 0.65
  • Revenue
  • VSTM $10,000,000.00
  • SCHL $1,592,100,000.00
  • Revenue This Year
  • VSTM $106.87
  • SCHL $3.42
  • Revenue Next Year
  • VSTM $312.95
  • SCHL $5.47
  • P/E Ratio
  • VSTM N/A
  • SCHL $26.49
  • Revenue Growth
  • VSTM N/A
  • SCHL N/A
  • 52 Week Low
  • VSTM $2.10
  • SCHL $15.77
  • 52 Week High
  • VSTM $9.10
  • SCHL $38.77
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 47.31
  • SCHL 40.57
  • Support Level
  • VSTM $7.60
  • SCHL $16.81
  • Resistance Level
  • VSTM $9.10
  • SCHL $17.85
  • Average True Range (ATR)
  • VSTM 0.88
  • SCHL 0.66
  • MACD
  • VSTM -0.09
  • SCHL -0.11
  • Stochastic Oscillator
  • VSTM 33.16
  • SCHL 5.04

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

Share on Social Networks: